C. Le

818 total citations
26 papers, 605 citations indexed

About

C. Le is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, C. Le has authored 26 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in C. Le's work include CAR-T cell therapy research (5 papers), Smoking Behavior and Cessation (4 papers) and Cell Adhesion Molecules Research (3 papers). C. Le is often cited by papers focused on CAR-T cell therapy research (5 papers), Smoking Behavior and Cessation (4 papers) and Cell Adhesion Molecules Research (3 papers). C. Le collaborates with scholars based in United States, France and Australia. C. Le's co-authors include JH Kersey, Mimi L.K. Tang, Anne Balloch, Robert Boyle, Stephen S. Hecht, Kyriakos A. Kirou, M. Pétri, Gabriel J. Robbie, R. D. Levin and Vishala Chindalore and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and American Journal of Public Health.

In The Last Decade

C. Le

25 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Le United States 12 238 161 133 127 94 26 605
Nan Hu China 13 286 1.2× 165 1.0× 372 2.8× 61 0.5× 24 0.3× 31 822
Atsuo Tanimoto Japan 12 196 0.8× 132 0.8× 72 0.5× 78 0.6× 38 0.4× 20 676
Violeta Régnier Galvão Brazil 14 257 1.1× 149 0.9× 72 0.5× 182 1.4× 65 0.7× 22 729
David Soler United States 12 249 1.0× 35 0.2× 134 1.0× 94 0.7× 42 0.4× 26 505
Cindy Gross United States 8 348 1.5× 189 1.2× 84 0.6× 175 1.4× 26 0.3× 13 694
Bo Cheng China 14 75 0.3× 100 0.6× 113 0.8× 76 0.6× 28 0.3× 41 478
Anna Wolska Poland 13 205 0.9× 49 0.3× 166 1.2× 148 1.2× 59 0.6× 29 512
Carole Ferraro France 5 157 0.7× 116 0.7× 160 1.2× 83 0.7× 26 0.3× 5 510
Tatsuya Sasakawa Japan 12 102 0.4× 97 0.6× 291 2.2× 68 0.5× 26 0.3× 13 633
Tadashi Hosoya Japan 12 262 1.1× 138 0.9× 136 1.0× 150 1.2× 19 0.2× 51 603

Countries citing papers authored by C. Le

Since Specialization
Citations

This map shows the geographic impact of C. Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Le more than expected).

Fields of papers citing papers by C. Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Le. The network helps show where C. Le may publish in the future.

Co-authorship network of co-authors of C. Le

This figure shows the co-authorship network connecting the top 25 collaborators of C. Le. A scholar is included among the top collaborators of C. Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Le. C. Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Le, C., et al.. (2025). Separation and recycling of hydrofluorocarbon refrigerant mixtures with fluoropolymer-coated hollow fiber membranes. Science Advances. 11(3). eadp7414–eadp7414. 1 indexed citations
4.
Sutton, Margie N., Abdur Rehman, C. Le, et al.. (2024). Imaging Activated Innate Immune Myeloid Cells in Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy. Blood. 144(Supplement 1). 3428–3428. 2 indexed citations
6.
Reville, Patrick K., Qing Deng, C. Le, et al.. (2023). SAR442257, a CD38/CD28/CD3 trispecific antibody, potentiates CAR T‐cell activity against large B‐cell lymphoma. Hematological Oncology. 41(S2). 275–276. 2 indexed citations
7.
Reville, Patrick K., Enyu Dai, Qing Deng, et al.. (2023). P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA. HemaSphere. 7(S3). e860097f–e860097f. 1 indexed citations
8.
Schneider, Christophe, Amar Bennasroune, Aurore Wolak‐Thierry, et al.. (2022). Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. Cancers. 14(4). 928–928. 11 indexed citations
9.
Le, C., Amar Bennasroune, Benoît Langlois, et al.. (2020). Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer. Frontiers in Oncology. 10. 527–527. 36 indexed citations
10.
Le, C., Amar Bennasroune, Guillaume Collin, et al.. (2020). LRP-1 Promotes Colon Cancer Cell Proliferation in 3D Collagen Matrices by Mediating DDR1 Endocytosis. Frontiers in Cell and Developmental Biology. 8. 412–412. 24 indexed citations
11.
Wyman, Arlene R., Manal Alaamery, Christina J. Allain, et al.. (2017). Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays. Cellular Signalling. 40. 73–80. 12 indexed citations
12.
Lane, Sarah, et al.. (2017). Can Cold Brew Coffee Be Convenient? A Pilot Study For Caffeine Content in Cold Brew Coffee Concentrate Using High Performance Liquid Chromatography. UVic’s Research and Learning Repository (University of Victoria). 8(1). 15–23. 23 indexed citations
13.
Merrill, JT, M. Pétri, Kyriakos A. Kirou, et al.. (2011). Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Annals of the Rheumatic Diseases. 70(11). 1905–1913. 191 indexed citations
14.
Pentel, Paul R., Daniel E. Keyler, Mark LeSage, et al.. (2006). Vaccination against nicotine does not prevent nicotine-induced changes in fetal nicotinic receptor binding and c-fos mRNA expression in rats. Neurotoxicology and Teratology. 28(5). 589–596. 13 indexed citations
15.
Hatsukami, Dorothy K., et al.. (2006). Smokeless tobacco brand switching: A means to reduce toxicant exposure?. Drug and Alcohol Dependence. 87(2-3). 217–224. 24 indexed citations
16.
Le, C., et al.. (2006). The Clinical Syndrome of Specific Antibody Deficiency (SAD) in Children. Journal of Allergy and Clinical Immunology. 117(2). S109–S109. 1 indexed citations
17.
Anderson, Kristin E., Steven G. Carmella, Robin Bliss, et al.. (2001). Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke. JNCI Journal of the National Cancer Institute. 93(5). 378–381. 83 indexed citations
18.
Le, C., et al.. (1998). Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects. Leukemia. 12(12). 2029–2033. 79 indexed citations
19.
Braun, Barbara L., David M. Murray, Peter J. Hannan, Stephen Sidney, & C. Le. (1996). Cocaine use and characteristics of young adult users from 1987 to 1992: the CARDIA Study. Coronary Artery Risk Development in Young Adults.. American Journal of Public Health. 86(12). 1736–1741. 18 indexed citations
20.
Le, C., et al.. (1984). Competing Risk Analysis for Life Table Data with known Observation Times. Biometrical Journal. 26(1). 111–118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026